Contact Us
Bifurcation Lesions Global Market Report 2025
Global Bifurcation Lesions Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Bifurcation Lesions Global Market Report 2025

By Types (One-Stent, Two-Stent), By Application (Coronary Vascular, Peripheral Vascular) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Bifurcation Lesions Market Overview

• Bifurcation Lesions market size has reached to $2.63 billion in 2024

• Expected to grow to $4.01 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%

• Growth Driver: Rising Geriatric Population Fuels Growth In The Bifurcation Lesions Market

• Market Trend: Advancements In Imaging And Procedure Devices

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Bifurcation Lesions Market?

Bifurcation lesions refer to a coronary artery constriction that occurs next to or involves the origin of a vital side branch one does not want to lose. It occurs when plaque deposits accumulate, and the artery becomes too small for adequate blood flow to your heart.

The main types of bifurcation lesions are one-stent and two-stent. One-stent bifurcation lesions refer to a procedure where the side branch is provisionally stented if the intervention is required owing to clinical complaints, angiographic results, or other adjunctive variables. The main branch is stented first in this approach. The bifurcation angle is determined by the internal angle between the main and side branches. These types of bifurcation lesions are applied in coronary and Peripheral Vascular.

Bifurcation Lesions Market Size and growth rate 2025 to 2029: Graph

What Is The Bifurcation Lesions Market Size 2025 And Growth Rate?

The bifurcation lesions market size has grown strongly in recent years. It will grow from $2.63 billion in 2024 to $2.84 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to rise in prevalence of coronary artery diseases, rise in geriatric population, rise in healthcare expenditure, economic growth.

What Is The Bifurcation Lesions Market Growth Forecast?

The bifurcation lesions market size is expected to see strong growth in the next few years. It will grow to $4.01 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing demand for minimally invasive surgeries, expansion of healthcare infrastructure and facilities, increasing prevalence of cardiovascular diseases, government healthcare policies. Major trends in the forecast period include patient-centric approaches, bioresorbable stents, integration of AI and machine learning, cross-specialty collaboration.

The forecast of 9.1% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on specialized guidewires and drug-coated balloons from Italy and the Netherlands, potentially causing supply shortages for complex coronary procedures.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Medical Equipment Industry?

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

How Is The Bifurcation Lesions Market Segmented?

1) By Types: One-Stent, Two-Stent

2) By Application: Coronary Vascular, Peripheral Vascular

Subsegments:

1) By One-Stent: Single-Stent Deployment, Balloon-Expandable Stents, Self-Expanding Stents

2) By Two-Stent: Crush Technique, T- or Y-Configuration Stenting, Side Branch Stenting Techniques

What Is Driving The Bifurcation Lesions Market? Rising Geriatric Population Fuels Growth In The Bifurcation Lesions Market

The increase in geriatric population is expected to drive the growth of the bifurcation lesions market. People whose age is more than 60 years are more likely to suffer a heart attack, a stroke, or develop coronary heart disease and heart failure than younger people. In such cases, bifurcation lesions help treat the blood clots to allow adequate blood flow to your heart. For instance, in October 2022, according to a report published by the World Health Organization (WHO), a Switzerland-based agency responsible for international public health, one in six people is expected to be 60 or older by the year 2030, in the entire world. By 2050, there will be 2.1 billion people worldwide who are 60 years old or older. The number of persons who are 80 years of age or older will increase by 426 million between 2020 and 2050 compared to the current population. Therefore, the increasing geriatric population will drive the bifurcation lesions industry growth.

What Is Driving The Bifurcation Lesions Market? Elevated Healthcare Expenditure Fuels Growth In The Bifurcation Lesions Market

The increasing healthcare expenditure is expected to boost the growth of the bifurcation lesions market going forward. Healthcare infrastructure refers to all costs or outlays for medical care, preventative measures, public health initiatives, rehabilitation, community health activities, and health research. Higher healthcare spending allows healthcare facilities to invest in state-of-the-art equipment and technologies, including advanced interventional cardiology devices for treating bifurcation lesions. For instancein November 2023, according to the Canadian Institute for Health Information, a Canada-based non-profit organization, total health spending in Canada is anticipated to rise by 2.8% in 2023, following a modest growth of just 1.5% in 2022. Therefore, the increasing healthcare expenditure is driving the growth of the bifurcation lesions industry.

Who Are The Major Players In The Global Bifurcation Lesions Market?

Major companies operating in the bifurcation lesions market include Boston Scientific Corporation, Terumo Medical Corporation, Spectranetics Corporation, Medtronic plc, Cardinal Health Inc., Cardinal Health Company, Abbott Laboratories, Biosensors International Group Ltd., B. Braun Melsungen AG, Cook Medical LLC, Cordis Corporation, Endologix Inc., W. L. Gore & Associates Inc., InspireMD Inc., MicroPort Scientific Corporation, OrbusNeich Medical Company Limited, Biotronik SE & Co. KG, Cardionovum GmbH, Elixir Medical Corporation, Medinol Ltd., Meril Life Sciences Pvt. Ltd., Opto Circuits (India) Ltd., QualiMed Innovative Medizinprodukte GmbH, Sahajanand Medical Technologies Pvt. Ltd., Svelte Medical Systems Inc., Translumina GmbH, Vascular Concepts Limited, Vascular Solutions Inc., Veryan Medical Ltd., X-Cell Medical Inc., Zorion Medical Inc., Amaranth Medical Inc., Cardiomind Inc., Cardiva Medical Inc.

What Are The Key Trends Of The Global Bifurcation Lesions Market? Advancements In Imaging And Procedure Devices

The advancement in devices used in imaging and procedures is a key trend that is gaining popularity in the bifurcation lesions market. Major companies operating in the market are concentrating their efforts on advancements in existing devices used in imaging and procedures. For instance, Advanced Bifurcation Systems (ABS), a clinical-stage medical device firm with a unique bifurcation stenting solution to standardize the treatment of all bifurcation lesions in coronary angioplasties, has a platform featuring the only modular self-aligning stent technology to evenly structure bifurcations. The ABS platform is a unique single system that reduces the need for repeat procedures and enables effective bifurcation stenting treatment.

What Are The Key Trends Of The Global Bifurcation Lesions Market? Product Innovations In Bifurcation Lesions Market

Major companies operating in the bifurcation lesions market are developing innovative products such as drug-eluting coronary stent systems to meet larger customer bases, more sales, and increase revenue. A drug-eluting coronary stent system is a medical device used in interventional cardiology to treat coronary artery disease. For instance, in August 2023, Medtronic Plc, an Ireland-based medical device company, launched Onyx Frontier drug-eluting stent (DES), for the management of non-left main bifurcation lesions using the provisional stenting technique. One distinguishing characteristic of this product is its design enhancements, which encompass an inventive dual-layer balloon, reduced crossing profile, and heightened catheter flexibility. These improvements result in a 16% enhancement in deliverability compared to the prior-generation Resolute Onyx DES, all while maintaining the same level of radial strength. Aside from the improvements in the delivery system, Onyx Frontier provides an extensive range of sizes, accommodating patients with diameters ranging from 2.0mm to 5.0mm. Notably, its 4.50-5.00 mm sizes can be expanded to 6.00mm, catering specifically to the treatment of extra-large vessels, including those in the left main. Onyx Frontier inherits the same clinical data and indications as Resolute Onyx, including approval for treating bifurcation lesions, left main percutaneous coronary intervention (PCI), and a recommended one-month duration of dual antiplatelet therapy (DAPT) for high bleeding risk patients.

Need data on a specific region in this market?

Bifurcation Lesions Market Merger And Acquisition: Silk Road Medical Announces Definitive Agreement To Be Acquired By Boston Scientific.

In June 2024, Boston Scientific Corporation, a US-based medical technology company, acquired Silk Road Medical, Inc. for$1.18 billion.. The aim is to strengthen Boston Scientific's product lineup and competitive standing in the vascular market by utilizing innovative technologies to enhance patient outcomes and expand into new markets. Silk Road Medical Inc. is a medical device company that specializes in creating innovative solutions for carotid artery procedures.

Regional Outlook For The Global Bifurcation Lesions Market

North America was the largest region in the bifurcation lesions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in this market report include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Defines the Bifurcation Lesions Market?

The bifurcation lesions market includes revenues earned by proximal main branch (MB), distal MB and side branch (SB). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Bifurcation Lesions Industry?

The bifurcation lesions market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bifurcation lesions industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Bifurcation Lesions Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $2.84 billion
Revenue Forecast In 2034 $4.01 billion
Growth Rate CAGR of 9.1% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Types: One-Stent, Two-Stent
2) By Application: Coronary Vascular, Peripheral Vascular Subsegments: 1) By One-Stent: Single-Stent Deployment, Balloon-Expandable Stents, Self-Expanding Stents
2) By Two-Stent: Crush Technique, T- or Y-Configuration Stenting, Side Branch Stenting Techniques
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Boston Scientific Corporation, Terumo Medical Corporation, Spectranetics Corporation, Medtronic plc, Cardinal Health Inc., Cardinal Health Company, Abbott Laboratories, Biosensors International Group Ltd., B. Braun Melsungen AG, Cook Medical LLC, Cordis Corporation, Endologix Inc., W. L. Gore & Associates Inc., InspireMD Inc., MicroPort Scientific Corporation, OrbusNeich Medical Company Limited, Biotronik SE & Co. KG, Cardionovum GmbH, Elixir Medical Corporation, Medinol Ltd., Meril Life Sciences Pvt. Ltd., Opto Circuits (India) Ltd., QualiMed Innovative Medizinprodukte GmbH, Sahajanand Medical Technologies Pvt. Ltd., Svelte Medical Systems Inc., Translumina GmbH, Vascular Concepts Limited, Vascular Solutions Inc., Veryan Medical Ltd., X-Cell Medical Inc., Zorion Medical Inc., Amaranth Medical Inc., Cardiomind Inc., Cardiva Medical Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Bifurcation Lesions Market Characteristics

3. Bifurcation Lesions Market Trends And Strategies

4. Bifurcation Lesions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Bifurcation Lesions Growth Analysis And Strategic Analysis Framework

5.1. Global Bifurcation Lesions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Bifurcation Lesions Market Growth Rate Analysis

5.4. Global Bifurcation Lesions Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Bifurcation Lesions Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Bifurcation Lesions Total Addressable Market (TAM)

6. Bifurcation Lesions Market Segmentation

6.1. Global Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

One-Stent

Two-Stent

6.2. Global Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Coronary Vascular

Peripheral Vascular

6.3. Global Bifurcation Lesions Market, Sub-Segmentation Of One-Stent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Single-Stent Deployment

Balloon-Expandable Stents

Self-Expanding Stents

6.4. Global Bifurcation Lesions Market, Sub-Segmentation Of Two-Stent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Crush Technique

T- or Y-Configuration Stenting

Side Branch Stenting Techniques

7. Bifurcation Lesions Market Regional And Country Analysis

7.1. Global Bifurcation Lesions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Bifurcation Lesions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bifurcation Lesions Market

8.1. Asia-Pacific Bifurcation Lesions Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bifurcation Lesions Market

9.1. China Bifurcation Lesions Market Overview

9.2. China Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bifurcation Lesions Market

10.1. India Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bifurcation Lesions Market

11.1. Japan Bifurcation Lesions Market Overview

11.2. Japan Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bifurcation Lesions Market

12.1. Australia Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bifurcation Lesions Market

13.1. Indonesia Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bifurcation Lesions Market

14.1. South Korea Bifurcation Lesions Market Overview

14.2. South Korea Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bifurcation Lesions Market

15.1. Western Europe Bifurcation Lesions Market Overview

15.2. Western Europe Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bifurcation Lesions Market

16.1. UK Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bifurcation Lesions Market

17.1. Germany Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bifurcation Lesions Market

18.1. France Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bifurcation Lesions Market

19.1. Italy Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bifurcation Lesions Market

20.1. Spain Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bifurcation Lesions Market

21.1. Eastern Europe Bifurcation Lesions Market Overview

21.2. Eastern Europe Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bifurcation Lesions Market

22.1. Russia Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bifurcation Lesions Market

23.1. North America Bifurcation Lesions Market Overview

23.2. North America Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bifurcation Lesions Market

24.1. USA Bifurcation Lesions Market Overview

24.2. USA Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bifurcation Lesions Market

25.1. Canada Bifurcation Lesions Market Overview

25.2. Canada Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bifurcation Lesions Market

26.1. South America Bifurcation Lesions Market Overview

26.2. South America Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bifurcation Lesions Market

27.1. Brazil Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bifurcation Lesions Market

28.1. Middle East Bifurcation Lesions Market Overview

28.2. Middle East Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bifurcation Lesions Market

29.1. Africa Bifurcation Lesions Market Overview

29.2. Africa Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bifurcation Lesions Market Competitive Landscape And Company Profiles

30.1. Bifurcation Lesions Market Competitive Landscape

30.2. Bifurcation Lesions Market Company Profiles

30.2.1. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Terumo Medical Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Spectranetics Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Bifurcation Lesions Market Other Major And Innovative Companies

31.1. Cardinal Health Company

31.2. Abbott Laboratories

31.3. Biosensors International Group Ltd.

31.4. B. Braun Melsungen AG

31.5. Cook Medical LLC

31.6. Cordis Corporation

31.7. Endologix Inc.

31.8. W. L. Gore & Associates Inc.

31.9. InspireMD Inc.

31.10. MicroPort Scientific Corporation

31.11. OrbusNeich Medical Company Limited

31.12. Biotronik SE & Co. KG

31.13. Cardionovum GmbH

31.14. Elixir Medical Corporation

31.15. Medinol Ltd.

32. Global Bifurcation Lesions Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bifurcation Lesions Market

34. Recent Developments In The Bifurcation Lesions Market

35. Bifurcation Lesions Market High Potential Countries, Segments and Strategies

35.1 Bifurcation Lesions Market In 2029 - Countries Offering Most New Opportunities

35.2 Bifurcation Lesions Market In 2029 - Segments Offering Most New Opportunities

35.3 Bifurcation Lesions Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Bifurcation Lesions Market, Sub-Segmentation Of One-Stent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Bifurcation Lesions Market, Sub-Segmentation Of Two-Stent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Bifurcation Lesions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Bifurcation Lesions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Asia-Pacific, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Asia-Pacific, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: China, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: China, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: India, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: India, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Japan, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Japan, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Australia, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: Australia, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Indonesia, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Indonesia, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: South Korea, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: South Korea, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Western Europe, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Western Europe, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: UK, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: UK, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Germany, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Germany, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: France, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: France, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Italy, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Italy, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Spain, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Spain, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Eastern Europe, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Eastern Europe, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Russia, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Russia, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: North America, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: North America, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: USA, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: USA, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Canada, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Canada, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: South America, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: South America, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Brazil, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Brazil, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Middle East, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Middle East, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Africa, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Africa, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Boston Scientific Corporation Financial Performance
  • Table 54: Terumo Medical Corporation Financial Performance
  • Table 55: Spectranetics Corporation Financial Performance
  • Table 56: Medtronic plc Financial Performance
  • Table 57: Cardinal Health Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Bifurcation Lesions Market, Sub-Segmentation Of One-Stent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Bifurcation Lesions Market, Sub-Segmentation Of Two-Stent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Bifurcation Lesions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Bifurcation Lesions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Asia-Pacific, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Asia-Pacific, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: China, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: China, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: India, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: India, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Japan, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Japan, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Australia, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: Australia, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Indonesia, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Indonesia, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: South Korea, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: South Korea, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Western Europe, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Western Europe, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: UK, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: UK, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Germany, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Germany, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: France, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: France, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Italy, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Italy, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Spain, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Spain, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Eastern Europe, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Eastern Europe, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Russia, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Russia, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: North America, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: North America, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: USA, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: USA, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Canada, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Canada, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: South America, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: South America, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Brazil, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Brazil, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Middle East, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Middle East, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Africa, Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Africa, Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Boston Scientific Corporation Financial Performance
  • Figure 54: Terumo Medical Corporation Financial Performance
  • Figure 55: Spectranetics Corporation Financial Performance
  • Figure 56: Medtronic plc Financial Performance
  • Figure 57: Cardinal Health Inc. Financial Performance

Frequently Asked Questions

Bifurcation lesions refer to a coronary artery constriction that occurs next to or involves the origin of a vital side branch one does not want to lose. It occurs when plaque deposits accumulate, and the artery becomes too small for adequate blood flow to your heart. For further insights on this market, request a sample here

The market major growth driver - Rising Geriatric Population Fuels Growth In The Bifurcation Lesions Market. For further insights on this market, request a sample here

The bifurcation lesions market size has grown strongly in recent years. It will grow from $2.63 billion in 2024 to $2.84 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to rise in prevalence of coronary artery diseases, rise in geriatric population, rise in healthcare expenditure, economic growth. The bifurcation lesions market size is expected to see strong growth in the next few years. It will grow to $4.01 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing demand for minimally invasive surgeries, expansion of healthcare infrastructure and facilities, increasing prevalence of cardiovascular diseases, government healthcare policies. Major trends in the forecast period include patient-centric approaches, bioresorbable stents, integration of ai and machine learning, cross-specialty collaboration. For further insights on this market, request a sample here

The bifurcation lesionsmarket covered in this report is segmented –
1) By Types: One-Stent, Two-Stent
2) By Application: Coronary Vascular, Peripheral Vascular Subsegments:
1) By One-Stent: Single-Stent Deployment, Balloon-Expandable Stents, Self-Expanding Stents
2) By Two-Stent: Crush Technique, T- or Y-Configuration Stenting, Side Branch Stenting Techniques For further insights on this market,
request a sample here

North America was the largest region in the bifurcation lesions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bifurcation lesions market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Major companies operating in the bifurcation lesions market include Boston Scientific Corporation, Terumo Medical Corporation, Spectranetics Corporation, Medtronic plc, Cardinal Health Inc., Cardinal Health Company, Abbott Laboratories, Biosensors International Group Ltd., B. Braun Melsungen AG, Cook Medical LLC, Cordis Corporation, Endologix Inc., W. L. Gore & Associates Inc., InspireMD Inc., MicroPort Scientific Corporation, OrbusNeich Medical Company Limited, Biotronik SE & Co. KG, Cardionovum GmbH, Elixir Medical Corporation, Medinol Ltd., Meril Life Sciences Pvt. Ltd., Opto Circuits (India) Ltd., QualiMed Innovative Medizinprodukte GmbH, Sahajanand Medical Technologies Pvt. Ltd., Svelte Medical Systems Inc., Translumina GmbH, Vascular Concepts Limited, Vascular Solutions Inc., Veryan Medical Ltd., X-Cell Medical Inc., Zorion Medical Inc., Amaranth Medical Inc., Cardiomind Inc., Cardiva Medical Inc. . For further insights on this market, request a sample here.

Major trends in this market include Advancements In Imaging And Procedure Devices. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top